| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |